Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

NCT03315364

Conditions
Breast Diseases, Breast Neoplasms, Disease Attributes, +8 more
Locations
  • Oncology Complex Center - Burgas'' Ltd., Medical Oncology Department Burgas, Bulgaria
  • Multi-profile Hospital for Active Treatment Uni Hospital Ltd. Medical Oncology Department Panagyurishte, Bulgaria
  • Medical Center Nadezhda Clinical" Ltd., Sofia, Bulgaria
  • Anhui Cancer Hospital Hefei, Anhui, China
View all 51 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood

NCT03793478

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • A.I. duPont Hospital for Children Wilmington, Delaware, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

NCT05552976

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Local Institution - 0046 Mobile, Alabama, United States
  • Local Institution - 0005 Cerritos, California, United States
  • Local Institution - 0190 Irvine, California, United States
  • Local Institution - 0187 Los Angeles, California, United States
View all 207 locations
View Trial Details
Active, Not Recruiting

Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

NCT04279847

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +19 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Emory University-Winship Cancer Institute Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT05020015

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • MedStar Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sylvester Comprehensive Cancer Center University of Miami Hospitals and Clinics Miami, Florida, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

NCT04756726

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California-San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute (Sarah Cannon Research Institute) Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma

NCT02298348

Conditions
Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children Hospital of Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

NCT02773030

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 102 Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Local Institution - 107 Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 162 locations
View Trial Details

Related conditions